PT  - JOURNAL ARTICLE
AU  - Stefano Testa
AU  - Carles Sanchez Riera
AU  - Ersilia Fornetti
AU  - Federica Riccio
AU  - Claudia Fuoco
AU  - Sergio Bernardini
AU  - Jacopo Baldi
AU  - Marco Costantini
AU  - Maria Laura Foddai
AU  - Stefano Cannata
AU  - Cesare Gargioli
TI  - Skeletal muscle-derived Human Mesenchymal Stem Cells: influence of different culture conditions on proliferative and myogenic capabilities
AID  - 10.1101/2020.05.12.090746
DP  - 2020 Jan 01
TA  - bioRxiv
PG  - 2020.05.12.090746
4099  - http://biorxiv.org/content/early/2020/05/13/2020.05.12.090746.short
4100  - http://biorxiv.org/content/early/2020/05/13/2020.05.12.090746.full
AB  - Skeletal muscle tissue is characterized by restrained self-regenerative capabilities, being ineffective in relation to trauma extension both in time span (e.g. chronic diseases) and in size (e.g. large trauma). For these reasons, tissue engineering and/or cellular therapies represent a valuable solution in the cases where the physiological healing process failed. Satellite cells, the putative skeletal muscle stem cells, have been the first solution explored to remedy the insufficient self-regeneration capacity. Nevertheless, some limitation related to donor age, muscle condition, expansion hitch and myogenic potentiality maintenance have limited their use as therapeutic tool. To overcome this hindrance, different stem cells population with myogenic capabilities have been investigated to evaluate their real potentiality for therapeutic approaches, but, as of today, the perfect cell candidate has not been identified yet.In this work, we analyze the characteristics of skeletal muscle-derived human Mesenchymal Stem Cells (hMSCs), showing the maintenance/increment of myogenic activity upon differential culture conditions. In particular, we investigate the influence of a commercial enriched growth medium (Cyto-Grow), and of a medium enriched with either human-derived serum (H.S.) or Platelet-rich Plasma (PrP), in order to set up a culture protocol useful for employing this cell population in clinical therapeutic strategies. The presented results reveal the remarkable effects of H.S. in the enhancement of hMSC proliferation and myogenic differentiation.Competing Interest StatementThe authors have declared no competing interest.